CirChem posted record Q3 sales and its first-ever quarterly profit, driven by surging demand and new partnerships, while investing in expanded production capacity and maintaining a strong equity ratio.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.